Sachin A Kumar

Employment

• Boston Children's Hospital Resident
  2023 - Present

Education

• University of Toronto MD/PhD
  2015 - 2023
• University of Toronto MSc
  2012 - 2015
• University of Toronto HBSc
  2008 - 2012

Projects & Funding

Projects & funding information is unavailable.

Publications (17)

• TULIPs decorate the three-dimensional genome of PFA ependymoma
  Cell 2024 DOI: 10.1016/j.cell.2024.06.023
  +Save
• The LIN28B–let‐7–PBK pathway is essential for group 3 medulloblastoma tumor growth and survival
  Molecular Oncology 2023 DOI: 10.1002/1878-0261.13477
  +Save
• 3D genome mapping identifies subgroup-specific chromosome conformations and tumor-dependency genes in ependymoma
  Nature Communications 2023 DOI: 10.1038/s41467-023-38044-0
  +Save
• Mechanosensitive brain tumor cells construct blood-tumor barrier to mask chemosensitivity
  Neuron 2023 DOI: 10.1016/j.neuron.2022.10.007
  +Save
• Failure of human rhombic lip differentiation underlies medulloblastoma formation
  Nature 2022 DOI: 10.1038/s41586-022-05215-w
  +Save
• Ultra high-risk PFA ependymoma is characterized by loss of chromosome 6q.
  Neuro-oncology 2021 DOI: 10.1093/neuonc/noab034
  +Save
• An independent appraisal and re-analysis of hydroxychloroquine treatment trial for COVID-19.
  Swiss medical weekly 2020 DOI: 10.4414/smw.2020.20262
  +Save
• Locoregional delivery of CAR T cells to the cerebrospinal fluid for treatment of metastatic medulloblastoma and ependymoma
  Nature Medicine 2020 DOI: 10.1038/s41591-020-0827-2
  +Save
• Metabolic Regulation of the Epigenome Drives Lethal Infantile Ependymoma
  Cell 2020 DOI: 10.1016/j.cell.2020.04.047
  +Save
• Modeling human brain tumours in flies, worms, and zebrafish: From proof of principle to novel therapeutic targets.
  Neuro-oncology 2020 DOI: 10.1093/neuonc/noaa306
  +Save